Maravai LifeSciences Holdings Inc reports results for the quarter ended in March - Earnings Summary

Maravai Lifesciences Holdings

06/05/2022 19:44

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 54 cents​​ per share for the quarter ended
in March. The mean expectation of nine analysts for the quarter
was for earnings of 44 cents per share.
    * Revenue rose 64.8% to $244.29 million from a year ago; 
analysts
expected $232.30 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was 50 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.8%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 19.1%
this quarter and lost 31.9% so far this year.
    * The company reported quarterly net income of $66.86
million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $44.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 6 at 06:43 p.m.  ​All
figures in US dollars unless otherwise stated